Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Economic Impact of Postoperative Urinary Retention in the US Hospital Setting
Marks‐Anglin, Arielle , Turzhitsky, Vladimir , Mark, Robert J., Rosales, Aurelio Otero, Bailey, Nathaniel W., Jiang, Yiling , Abueg, Joseph, Hofer, Ira , Wang, Weijia, Bailey, Nathaniel W., Weingarten, Toby N.

Journal of Health Economics and Outcomes Research | August 8, 2024 | Volume: 11 | Issue: 2 | Pages: No page available

10.36469/001c.121641 | PMID 39267889 Get It

Background Postoperative urinary retention (POUR) is a common and distressing surgical complication that may be associated with the pharmacological reversal technique of neuromuscular blockade (NMB). Objective This study aimed to investigate the impact that POUR has on medical charges. Methods This was a retrospective observational study of adult patients undergoing select surgeries who were administered neuromuscular blockade agent (NMBA), which was pharmacologically reversed between February 2017 and November 2021 using data from the PINC-AI™ Healthcare Database. Patients were divided into 2 groups: those experiencing POUR (composite of retention of urine, insertion of temporary indwelling bladder catheter, insertion of non-indwelling bladder catheter) during index hospitalization following surgery and those without POUR. Surgeries in inpatient and outpatient settings were analyzed separately. A cross-sectional comparison was performed to report total hospital charges for the 2 groups. Furthermore, patients experiencing subsequent POUR events within three days after discharge from index hospitalization were studied. Results A total of 330 838 inpatients and 437 063 outpatients were included. POUR developed in 13 020 inpatients and 2756 outpatients. Unadjusted results showed that POUR was associated with greater charges in both inpatient ($92 529 with POUR vs $78 556 without POUR, p < .001) and outpatient ($48 996 with POUR vs $35 433 without POUR, p < .001) settings. After adjusting for confounders, POUR was found to be associated with greater charges with an overall mean adjusted difference of $10 668 (95% confidence interval [CI] $95 760-$11 760, p < .001) in inpatient and $13 160 (95% CI $11 750-$14 571, p < .001) in outpatient settings. Charges associated with subsequent POUR events following discharge ranged from $9418 inpatient charges to $1694 outpatient charges. Conclusions Surgical patients who were pharmacologically reversed for NMB and developed a POUR event incurred greater charges than patients without POUR. These findings support the use of NMB reversal agents associated with a lower incidence of POUR.
Design and validation of the ADNI MR protocol
Arani, Arvin , Borowski, Bret, Felmlee, John, Thomas, David L. , Gunter, Jeffrey L. , Stables, Lara, Jung, Youngkyoo , Tosun, Duygu , Weiner, Michael W. , Jack, Clifford R. , Initiative, for the Alzheimer's Disease Neuroimaging, Tosun, Duygu , Jack, Clifford R , Arani, Arvin , Tosun, Duygu , Reid, Robert I. , Buckner, Randy L. , Initiative, for the Alzheimer's Disease Neuroimaging

Alzheimer's & Dementia | August 8, 2024 | Volume: 20 | Issue: 9 | Pages: 6615-6621

10.1002/alz.14162 | PMID 39115941 Get It

AbstractPhase four of the Alzheimer's Disease Neuroimaging Initiative (ADNI4) magnetic resonance imaging (MRI) protocols aim to maintain longitudinal consistency across two decades of data acquisition, while adopting new technologies. Here we describe and justify the study's design and targeted biomarkers. The ADNI4 MRI protocol includes nine MRI sequences. Some sequences require the latest hardware and software system upgrades and are continuously rolled out as they become available at each site. The main sequence additions/changes in ADNI4 are: (1) compressed sensing (CS) T1‐weighting, (2) pseudo‐continuous arterial spin labeling (ASL) on all three vendors (GE, Siemens, Philips), (3) multiple‐post‐labeling‐delay ASL, (4) 1 mm3 isotropic 3D fluid‐attenuated inversion recovery, and (5) CS 3D T2‐weighted. ADNI4 aims to help the neuroimaging community extract valuable imaging biomarkers and provide a database to test the impact of advanced imaging strategies on diagnostic accuracy and disease sensitivity among individuals lying on the cognitively normal to impaired spectrum.Highlights A summary of MRI protocols for phase four of the Alzheimer's Disease Neuroimaging Initiative (ADNI 4). The design and justification for the ADNI 4 MRI protocols. Compressed sensing and multi‐band advances have been applied to improve scan time. ADNI4 protocols aim to streamline safety screening and therapy monitoring. The ADNI4 database will be a valuable test bed for academic research.
Reply by Authors
Trost, L., Mulhall, J., Trost, Landon , Hellstrom, Wayne J.G.

Journal of Urology | August 8, 2024 | Volume: 212 | Issue: 3 | Pages: 480-481

10.1097/ju.0000000000004112 | PMID 39115124 Get It

Reply by Authors
Trost, Landon , Mulhall, J., Hellstrom, Wayne J.G.

Journal of Urology | August 8, 2024 | Volume: 212 | Issue: 3 | Pages: 481-482

10.1097/ju.0000000000004109 | PMID 39115129 Get It

Creation of a Novel Classification System (PTNM) for Peyronie’s Disease and Penile Curvature Using Evidence-Based Criteria
Trost, Landon , Mulhall, John P. , Hellstrom, Wayne J.G.

Journal of Urology | August 8, 2024 | Volume: 212 | Issue: 3 | Pages: 470-482

10.1097/ju.0000000000004072 | PMID 39115123 Get It

Belonging, Affirmation, Safety, and Efficacy (BASE): An Integrative Model for Shame Resilience, Social Support, and Humor in r/hemorrhoid
Amangalieva, Gulmira , Britt, Rebecca K. , Carmack, Heather J. , Holiday, Steven , Ivic, Rebecca K

Health Communication | August 8, 2024 | Volume: 40 | Issue: 6 | Pages: 1078-1089

10.1080/10410236.2024.2386714 | PMID 39114976 Get It

Persistent hypoxemia in a child with medulloblastoma following a third autologous stem cell transplant
Holthe, Jordan , Boesch, Paul, Kohorst, Mira A. , Schwartz, Jonathan, Boesch, Paul, Ferdjallah, Asmaa

Pediatric Pulmonology | August 8, 2024 | Volume: 59 | Issue: 12 | Pages: 3686-3691

10.1002/ppul.27194 | PMID 39115448 Get It

Polygenic Risk and Coronary Artery Disease Severity
Sherafati, Alborz , Norland, Kristján , Naderian, Mohammadreza , Schaid, Daniel J. , Kullo, Iftikhar J. , Kullo, Iftikhar J , Naderian, Mohammadreza

Circulation: Genomic and Precision Medicine | August 8, 2024 | Volume: 17 | Issue: 5 | Pages: No page available

10.1161/circgen.123.004470 | PMID 39114909 Get It

BACKGROUND: Coronary atherosclerotic burden and adverse coronary heart disease events are related phenotypes with likely shared genetic cause. METHODS: We analyzed 6021 patients with available coronary angiography, genotyping, and exome sequencing data. We tested for associations of polygenic risk scores for coronary heart disease (PRS CHD ) with multiple measures of coronary artery disease (CAD) severity. We assessed the joint associations of PRS CHD and pathogenic/likely pathogenic variants in 3 familial hypercholesterolemia genes, with CAD severity. We performed mediation analyses to explore whether CAD severity mediated the association of PRS CHD with prevalent coronary heart disease and incident myocardial infarction. RESULTS: A 1-SD increase in PRS CHD was associated with multiple measures of CAD severity, including the log Gensini score (β, 0.31 [95% CI, 0.28–0.33]). Carrying a pathogenic/likely pathogenic familial hypercholesterolemia variant was associated with a higher log Gensini score after adjustment for PRS CHD (β, 0.21 [95% CI, 0.03–0.38]). A 1-SD increase in PRS CHD was associated with incident myocardial infarction over a mean follow-up of 9.2 years (hazard ratio, 1.20 [95% CI, 1.13–1.27]; P =5×10 − 10 ), and the Gensini score mediated 90% of this association. CONCLUSIONS: PRS CHD was associated with multiple measures of CAD severity. The association of PRS CHD with incident myocardial infarction was almost fully mediated by CAD severity, indicating a considerable genetic overlap between the 2 phenotypes.
Artificial Intelligence and Health Inequities in Dietary Interventions on Atherosclerosis: A Narrative Review
Mackay, K. , Monlezun, Dominique J , MacKay, Keir , Monlezun, Dominique

Nutrients | August 8, 2024 | Volume: 16 | Issue: 16 | Pages: 2601

10.3390/nu16162601 | PMID 39203738 Get It

Poor diet is the top modifiable mortality risk factor globally, accounting for 11 million deaths annually with half being from diet-linked atherosclerotic cardiovascular disease (ASCVD). Yet, most of the world cannot afford a healthy diet—as the hidden costs of the inadequate global food system total over USD 13 trillion annually—let alone the much more clinically, financially, and ecologically costly and resource-intensive medical interventions required to address the disease progression and acute complications of ASCVD. Yet, AI is increasingly understood as a force multiplying revolutionary technology which may catalyze multi-sector efforts in medicine and public health to better address these significant health challenges. This novel narrative review seeks to provide the first known overview of the state-of-the-art in clinical interventions and public health policies in healthy diets for ASCVD, accelerated by health equity-focused AI. It is written from the first-hand practitioner perspective to provide greater relevance and applicability for health professionals and data scientists. The review summarizes the emerging trends and leading use cases in population health risk stratification and precision public health, AI democratizing clinical diagnosis, digital twins in precision nutrition, and AI-enabled culinary medicine as medical education and treatment. This review may, therefore, help inform and advance the evidence-based foundation for more clinically effective, financially efficient, and societally equitable dietary and nutrition interventions for ASCVD.
Optimizing Access in Hip Arthroscopy
Richardson, Meghan W., Goodloe, J. Brett , Gwathmey, F. Winston , Su, Charles A.

Video Journal of Sports Medicine | August 8, 2024 | Volume: 4 | Issue: 4 | Pages: No page available

10.1177/26350254241241080 | PMID 40309055 Get It

Background: Arthroscopic access to the hip can be challenging. We present a reproducible, safe, and efficient method for arthroscopic access to the hip. This can be especially beneficial for hips that may be predisposed to more difficult access. Indications: Hip arthroscopy is indicated in patients with symptomatic femoral acetabular impingement (FAI) who have failed conservative treatment options. FAI surgery aims to address both bony impingement and labral pathology in the hip. Technique: In this technique, we describe methodical steps to hip access. These steps include special attention to patient positioning and preoperative radiographs, air arthrogram, bevel control for needle joint entry, careful interpretation of intraoperative fluoroscopy, and adequate capsulotomy for viewing. Results: The majority of patients undergoing hip arthroscopy for FAI have improvements in both hip function and pain. Preoperative findings of increased center edge angle and male sex may predispose patients to more difficult hip arthroscopy access. The use of this technique may aid in reproducible access. Discussion/Conclusion: Hip arthroscopy is a good option for patients who have failed conservative treatment options and have signs and symptoms of FAI. Reproducible, safe, and efficient access to the hip is critical to starting hip arthroscopy cases. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.